Literature DB >> 22740821

Hypertrophic pulmonary osteoarthropathy with positive antinuclear antibodies: case report.

C Cruz1, M Rocha, D Andrade, F Guimarães, V Silva, S Souza, C A Moura, C G Moura.   

Abstract

A male Afro-descendant patient, 57 years old, complaining of polyarticular involvement and weight loss for 18 months, with a load of 13.5 pack years of smoking. On physical examination there was pain on palpation of the right knee and right leg, with signs of inflammation on the knee. We also observed digital clubbing in all fingers. Antinuclear antibodies (ANA) and anti-Sm antibodies were positive. X-rays of the legs and arm showed cortical thickening of long bones. The computed tomography demonstrated a large mass located in the middle lobe of the right lung. The anatomopathological study revealed a bronchial adenocarcinoma. The history of polyarticular involvement associated with positive anti-Sm and ANA antibodies could lead to an erroneous diagnosis of systemic lupus erythematosus. Considering the bad consequences of delayed diagnosis in this patient, the medical team should be alerted for suspecting and look for a lung cancer under these circumstances.

Entities:  

Keywords:  Antinuclear antibodies; Bronchial adenocarcinoma; Hypertrophic pulmonary osteoarthropathy

Year:  2012        PMID: 22740821      PMCID: PMC3383253          DOI: 10.1159/000339571

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Introduction

The term ‘pulmonary hypertrophic osteoarthropathy’ (PHO) was proposed by Marie in 1890, while one year before Bamberger had described two patients with hypertrophic osteoarthropathy related to bronchiectasis [1]. PHO, also known as Pierre Marie-Bamberger Syndrome, is characterized by proliferative periostitis of long bones, digital clubbing, polyarticular or oligoarticular manifestations [2]. It is commonly associated with intrathoracic malignancies, and related to primary lung cancer in 80% of patients. According to the literature 0.2% to 17% of patients with lung cancer develop PHO [1]. The literature has described the syndrome in the absence of antinuclear antibodies. Solans-Laqué et al. [3], nevertheless, have demonstrated antinuclear autoantibodies (ANA) in 27.7% of patients with malignancies when compared with only 6.4% in healthy subjects. Shoenfeld and colleagues [4] found anti-RNP and anti-Sm antibodies in 16 (21.7%) and 14 lymphoma patients (20%), respectively, significantly more than in the controls (p < 0.05) in both antibodies. These findings were valid for those with Hodgkin and non-Hodgkin lymphoma. We report herein a case of PHO with polyarticular involvement and detectable antinuclear and anti-Sm antibodies.

Case Report

A male, Afro-descendant 57-year-old complained of pain of strong intensity in the right ankle, right shoulder joints, and both knees with local edema eighteen months ago. The patient did not notice triggers of pain but had improvement with anti-inflammatory medicines. He did not mention alopecia, malar rash, photosensitivity, dark urine, decreased urine volume, seizures and behavior changes. He observed weight loss of 11 kg in recent months, sporadic dry cough and an episode of coughing up bloody sputum a month ago. He is a former smoker and had quit smoking for 13 years, with a load of 13.5 pack years of smoking. Laboratory tests requested on another rheumatologic clinic revealed: red blood cell counts 4,880,000/ml, hemoglobin 10.2 g/dl, hematocrit 33.9%, with negative Coombs, platelets 520,000/ml, total leukocyte count 8,000/ml, erythrocyte sedimentation rate 51 mm/first hour, urea 32 mg/dl, creatinine 0.8 mg/dl, AST 33 U/l, ALT 20 U/l, gamma-GT 107 U/l, C-reactive protein 143.0 mg/l, Waaler-Rose 256 IU/ml, positive ANA 1/5,120 (speckled pattern), anti-DNA negative, anti-Sm 156 (repeated and confirmed in independent samples of serum), IgG and IgM serology for Epstein-Barr was negative; C3 171.0, C4 32.60, rheumatoid factor 429 IU/ml, normal urine exam, 24-hour proteinuria 216 mg. On physical examination the patient was thin, afebrile, with digital clubbing in all fingers (fig. ). Examination of skin showed no malar rash or alopecia. Oropharyngeal examination did not present ulcers. Osteoarticular apparatus: there was pain on palpation of the right knee and right leg, with signs of inflammation on the right knee. Respiratory system: reduced breath sounds in the lower two-thirds of the right hemithorax without stertors and no pleural rub. Cardiovascular system: blood pressure 125 × 75 mm Hg, HR 84 bpm, normal and rhythmic beats in two phases, with no murmurs and no pericardial rub. Neurological exam: no abnormal findings. Among imaging tests performed, chest X-rays showed homogeneous opacity of partially defined contours, located in the anterior portions of the right lung basis. Computed tomography demonstrated a large mass (10.0 × 10.0 cm in greatest diameter) with heterogeneous density at the expense of central necrosis, located in the middle lobe of the right lung (fig. ). X-rays of the legs and arm showed cortical thickening of long bones (fig. ). Bronchoscopy showed in the right bronchial tree a vegetative tumor with friable coating almost completely obstructing the lumen of the bronchus. The anatomopathological study revealed a bronchial adenocarcinoma.

Discussion

PHO has been described in the literature with negative ANA, but the presence of these antibodies has been related to cancer [3]. Madrid et al. [5] found that presence of ANA was consistent in most lung cancer patients in their casuistic in a dilution of up to 1:500. The significance of antinuclear antibodies in malignancies is not well understood according to Zuber [6]. The antigens may be specific to each type of tumor and the production of antibodies would be an attempt to neutralize them. Cancer patients may develop many kinds of autoantibodies resulting from tissue damage and necrosis, allowing the generation of proteins that are usually not recognized by the immune system. The occurrence of articular involvement with positive ANA and anti-Sm is the unusual presentation in this case report. Anti-Sm antibodies (ELISA) have been pointed out as having a high specificity for lupus diagnosis (95–98%) [6]. False positives have been reported in cases of Hodgkin and non-Hodgkin lymphoma [4], rheumatoid arthritis [7], infection with Epstein-Barr virus [8], Malaysian ethnicity [9], relatives of schizophrenics and schizophrenics [10]. Considering the size of the mass (10.0 × 10.0 cm in greatest diameter), it is reasonable to assume that lung cancer was already present when the patient developed severe pain involving the right ankle, right shoulder and both knees eighteen months before hospitalization. This temporal relationship between the malignancy and the appearance of osteoarticular signs and symptoms according to McLean [11] reinforces the diagnosis of a paraneoplastic syndrome. The history of polyarticular involvement associated with positive anti-Sm and ANA could lead to an erroneous diagnosis of systemic lupus erythematosus, since these antibodies are highly specific for the diagnosis of this disease. Considering the bad consequences of delayed diagnosis in a patient with bronchial adenocarcinoma, the medical team should be alerted for suspecting and look for a lung cancer under these circumstances.
  11 in total

1.  Autoantibodies in the sera of patients with lymphoma.

Authors:  M Swissa; Y Cohen; Y Shoenfeld
Journal:  Leuk Lymphoma       Date:  1992-05

Review 2.  Anti-Sm and anti-RNP antibodies.

Authors:  P Migliorini; C Baldini; V Rocchi; S Bombardieri
Journal:  Autoimmunity       Date:  2005-02       Impact factor: 2.815

3.  [Secondary hypertrophic osteoarthropathy to lung cancer: a case report].

Authors:  Angelo Ferreira da Silva Junior; Eduardo Garcia; Fabíola Schorr; Amanda Barreto da Silva; Lucas Medeiros; Andre Barreto da Silva
Journal:  Rev Port Pneumol       Date:  2009 Jul-Aug

4.  The prevalence of antinuclear, anti-dsDNA, anti-Sm and anti-RNP antibodies in a group of healthy blood donors.

Authors:  M R Azizah; M N Azila; M N Zulkifli; T Y Norita
Journal:  Asian Pac J Allergy Immunol       Date:  1996-12       Impact factor: 2.310

5.  Cutaneous paraneoplastic syndromes.

Authors:  D I McLean
Journal:  Arch Dermatol       Date:  1986-07

6.  Antinuclear antibodies as potential markers of lung cancer.

Authors:  F Fernández-Madrid; P J VandeVord; X Yang; R L Karvonen; P M Simpson; M J Kraut; J L Granda; J E Tomkiel
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

7.  Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.

Authors:  C Tolosa-Vilella; J Ordi-Ros; M Vilardell-Tarres; A Selva-O'Callaghan; R Jordana-Comajuncosa
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

8.  Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.

Authors:  R Solans-Laqué; C Pérez-Bocanegra; A Salud-Salvia; V Fonollosa-Plá; M J Rodrigo; L Armadans; C P Simeón-Aznar; M Vilardell-Tarres
Journal:  Lupus       Date:  2004       Impact factor: 2.911

9.  Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera.

Authors:  P J Maddison; R P Skinner; P Vlachoyiannopoulos; D M Brennand; D Hough
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

10.  Increased anti-Sm antibodies in schizophrenic patients and their families.

Authors:  P Sirota; M Firer; K Schild; N Zurgil; Y Barak; A Elizur; H Slor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1993-09       Impact factor: 5.067

View more
  4 in total

Review 1.  Lung cancer mimicking systemic lupus erythematosus: case-based review.

Authors:  Jia Liu; Song Hu; Min Niu; Hua Wang; Yan Wang; Ning Tang; Bin Liu
Journal:  Rheumatol Int       Date:  2019-10-14       Impact factor: 2.631

2.  An Unusual Mimicker of Systemic Lupus Erythematosus: A Case Report.

Authors:  Aloice O Aluoch; Mathew Farbman; Heather Gladue
Journal:  Open Rheumatol J       Date:  2015-06-12

3.  A Case of Hypertrophic Pulmonary Osteoarthropathy in Both Upper and Lower Extremities: A Rare Involvement.

Authors:  Berna Okudan; Nazım Coşkun; Pelin Arıcan; Rıza Şefizade; Seniha Naldöken
Journal:  Mol Imaging Radionucl Ther       Date:  2018-06-07

Review 4.  Hypertrophic osteoarthropathy mimicking a reactive arthritis: a case report and review of the literature.

Authors:  Francesco Bozzao; Stella Bernardi; Franca Dore; Lorenzo Zandonà; Fabio Fischetti
Journal:  BMC Musculoskelet Disord       Date:  2018-05-14       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.